Conclusively, LINC01764 promotes CRC progression and 5‐FU resistance through hnRNPK‐mediated‐c‐MYC IRES‐dependent translational regulation, which suggests its potential as a predictor of CRC chemotherapy response and prognosis. The gene discussed is MYC; the disease is colorectal carcinoma.